whereas in lymph nodes and bony metastasis the increase was seen in 7(44%) and 10(57%) lesions, respectively. In these lesions with SUVmax increase, the peak value (a mean of 13% increase in SUVmax in prostatic lesions, 9% in lymph nodes and 47% in bony metastasis) was reached within 2-3 weeks. In one patient, three new bony lesions were detected at week two.
INTRODUCTION AND OBJECTIVES: 68Ga Prostate specific membrane antigen (PSMA) positron emission tomography (PET) represents an emerging method for primary prostate cancer staging of regional and distant metastases. Limited data on primary tumour characterisation appear promising, hence this study sought to assess the accuracy of 68Ga-PSMA PET/CT compared with multiparametric MRI (mpMRI) relative to prostate biopsy histopathology.
METHODS: A retrospective study was performed to include patients who underwent mpMRI, 68Ga-PSMA PET/CT and prostate biopsy between June 2014 and July 2017 in an academic, tertiary referral centre where a mpMRI-based triage pathway is routinely used. Use of 68Ga-PSMA PET/CT was performed more commonly in recent years with wider acceptance and incorporation into clinical practice. Standard clinical parameters were collected. Lesions were determined as likely, equivocal or unlikely for mpMRI (PIRADS 4 or 5, PIRADS 3, PIRADS 2 or 1) and 68Ga-PSMA PET/CT (high avidity, low avidity and no avidity), respectively. Analysis was performed on a "per patient" and "per lesion" basis for assessing lesion concordance between both imaging modalities and prostate biopsy histopathology.
RESULTS: 144 patients (median age 66.5 years, median PSA 8.6 ng/ml) underwent mpMRI, biopsy and 68Ga-PSMA PET/CT. Most patients were intermediate-high risk, with 46.5% and 47.9% of patients demonstrating Gleason 4þ3 or Gleason ! 4þ4 on biopsy. On per patient analysis, mpMRI and 68Ga-PSMA PET/CT showed concordance with 83.0% and 92.2% of index lesions respectively. For likely or equivocal lesions, high sensitivity was observed for 68Ga-PSMA PET/CT (98.4%) and mpMRI (90.1%), while per lesion analysis showed 68Ga-PSMA PET/CT (n [ 169) identified more histologically-confirmed lesions than mpMRI (n [ 149).
CONCLUSIONS: 68Ga-PSMA PET/CT is highly sensitive at index lesion identification and detects multifocal disease more accurately than mpMRI. These findings support further research into the role of 68Ga-PSMA PET/CT in pre-treatment staging of prostate cancer.
Source of Funding: None

MP74-19 ASSESSMENT OF RADIATION SAFETY KNOWLEDGE AMONG UROLOGY RESIDENTS IN THE UNITED STATES
Marilyn Hopkins*, John Loomis, Jason Bylund, Andrew Harris, Lexington, KY INTRODUCTION AND OBJECTIVES: Urologists are increasingly exposed to fluoroscopy as minimally invasive techniques continue to become more widespread. Fluoroscopy, or electromagnetic radiation, can be harmful due to cellular damage. Appropriate knowledge and safety precautions concerning fluoroscopy ared necessary and ideally should be taught in training.
METHODS: A 19-question survey was constructed to assess radiation safety training, knowledge, behavior, and attitudes. The survey was sent via REDCapTM to all Urology program directors in the United States with a request to forward this to their residents. The survey was closed after 3 weeks.
RESULTS: 136 urology trainees responded during the study period. 13% learned fluoroscopic radiation safety formally, 46% informally, 35% both informally and formally, 6% no education. 46% reported radiation safety being part of their curriculum. Only 50% have received training in residency. When asked about directional X-ray travel and exposure, 54% answered correctly with 15% being unsure, 6% stating no difference, and 26% choosing X-ray originating below the
